These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26635627)

  • 1. Obesity-Driven Gut Microbiota Inflammatory Pathways to Metabolic Syndrome.
    Cavalcante-Silva LH; Galvão JG; da Silva JS; de Sales-Neto JM; Rodrigues-Mascarenhas S
    Front Physiol; 2015; 6():341. PubMed ID: 26635627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota, inflammation and obesity.
    Sanz Y; Moya-Pérez A
    Adv Exp Med Biol; 2014; 817():291-317. PubMed ID: 24997040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate sensors of pathogen and stress: linking inflammation to obesity.
    Jin C; Flavell RA
    J Allergy Clin Immunol; 2013 Aug; 132(2):287-94. PubMed ID: 23905917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
    Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
    Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.
    Escobedo G; López-Ortiz E; Torres-Castro I
    Rev Invest Clin; 2014; 66(5):450-9. PubMed ID: 25695388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties.
    Vezza T; Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Romero M; Sánchez M; Toral M; Martín-García B; Gómez-Caravaca AM; Arráez-Román D; Segura-Carretero A; Micol V; García F; Utrilla MP; Duarte J; Rodríguez-Cabezas ME; Gálvez J
    Pharmacol Res; 2019 Dec; 150():104487. PubMed ID: 31610229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antigen presentation in the production of pro-inflammatory cytokines in obese adipose tissue.
    Majdoubi A; Kishta OA; Thibodeau J
    Cytokine; 2016 Jun; 82():112-21. PubMed ID: 26854212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation.
    McPhee JB; Schertzer JD
    Clin Sci (Lond); 2015 Dec; 129(12):1083-96. PubMed ID: 26464517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arachidonic acid sex-dependently affects obesity through linking gut microbiota-driven inflammation to hypothalamus-adipose-liver axis.
    Zhuang P; Shou Q; Lu Y; Wang G; Qiu J; Wang J; He L; Chen J; Jiao J; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2715-2726. PubMed ID: 28711599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice.
    Moya-Pérez A; Neef A; Sanz Y
    PLoS One; 2015; 10(7):e0126976. PubMed ID: 26161548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between gut microbiota and toll-like receptor: from immunity to metabolism.
    Yiu JH; Dorweiler B; Woo CW
    J Mol Med (Berl); 2017 Jan; 95(1):13-20. PubMed ID: 27639584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.
    Caesar R; Fåk F; Bäckhed F
    J Intern Med; 2010 Oct; 268(4):320-8. PubMed ID: 21050286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic interplay between metabolic syndrome and immunity.
    Paragh G; Seres I; Harangi M; Fülöp P
    Adv Exp Med Biol; 2014; 824():171-90. PubMed ID: 25039000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes.
    Zatterale F; Longo M; Naderi J; Raciti GA; Desiderio A; Miele C; Beguinot F
    Front Physiol; 2019; 10():1607. PubMed ID: 32063863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity.
    Hersoug LG; Møller P; Loft S
    Nutr Res Rev; 2018 Dec; 31(2):153-163. PubMed ID: 29362018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathology of Adipose Tissue during Metabolic Syndrome.
    Ghazarian M; Luck H; Revelo XS; Winer S; Winer DA
    Turk Patoloji Derg; 2015; 31 Suppl 1():172-80. PubMed ID: 26177326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota.
    Janssen AWF; Katiraei S; Bartosinska B; Eberhard D; Willems van Dijk K; Kersten S
    Diabetologia; 2018 Jun; 61(6):1447-1458. PubMed ID: 29502266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of inflammatory signaling pathways in obesity-induced insulin resistance.
    Tanti JF; Ceppo F; Jager J; Berthou F
    Front Endocrinol (Lausanne); 2012; 3():181. PubMed ID: 23316186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.